Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-03-12
1999-09-07
Krass, Frederick
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142225, 5142238, 514247, 514249, 514255, 514258, 514349, 514869, A61K 3855
Patent
active
059487992
ABSTRACT:
This invention relates to a method for reducing morbidity and/or mortality in a mammal with congestive heart failure due to non-ischemic etiology comprising administering amlodipine or a pharmaceutically acceptable amlodipine acid addition salt, and, optionally, a diuretic and/or digoxin. The invention further relates to methods for treating patients with congestive heart failure due to non-ischemic etiology, comprising administering a non-ischemic congestive heart failure treating amount of amlodipine or a pharmaceutically acceptable amlodipine salt and, optionally, a diuretic and/or digoxin. The invention also provides a kit which comprises a container means and a) amlodipine and a diuretic, b) amlodipine and digoxin, or c) amlodipine, digoxin and a diuretic; and a kit which comprises a container means and a) amlodipine, an angiotensin converting enzyme (ACE) inhibitor and a diuretic, b) amlodipine, an ACE inhibitor and digoxin, or c) amlodipine, an ACE inhibitor, digoxin and a diuretic. Further, this invention relates to compositions comprising amlodipine or a pharmaceutically acceptable salt thereof and one or both of digoxin and/or a diuretic.
REFERENCES:
patent: 5098910 (1992-03-01), Becker et al.
patent: 5155120 (1992-10-01), Lazar et al.
Sun, J. X. et al., European Journal of Clinical Pharmacology, vol. 47, No. 3, 1994, pp. 285-289.
Packer, M. et al., Supplement to Journal of the American College of Cardiology, vol. 17, No. 2, Supplement A, 274A, Mar. 6, 1991, 2:30 p.m.
Cohn, J. N., Drugs, vol. 47, Supplement 4, 1994, pp. 47-58.
Elkayam, U. et al., Supplement to Journal of the American College of Cardiology, vol. 22, No. 4, Oct. 1993: 139A-144A.
Singh, S. et al., The New England Journal of Medicine, vol. 333, No. 2, Jul. 13, 1995, pp. 77-82.
Packer, M. et al., The New England Journal of Medicine, vol. 335, No. 15, Oct. 10, 1996, pp. 1107-1114.
CIBIS Investigators and Committees, The Cardiac Insufficiency Bisoprolol Study (CIBIS), Circulation vol. 90, No. 4, Oct. 1994, pp. 1765-1773.
Benson Gregg C.
Kispert Jennifer A.
Krass Frederick
Pfizer Inc.
Richardson Peter C.
LandOfFree
Method for improving morbidity and/or mortality does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for improving morbidity and/or mortality, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for improving morbidity and/or mortality will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1804832